-

Feinstein Institutes lupus researchers recognized with top honors

Betty Diamond, MD, and Anne Davidson, MBBS, were named 2022 award recipients by the American College of Rheumatology and Association of Rheumatology Professionals for their outstanding contributions to the field of rheumatology

original Drs. Anne Davidson (left) and Betty Diamond received top honors from the American College of Rheumatology (ACR) and the Association of Rheumatology Professionals. (Photo: Business Wire)

Drs. Anne Davidson (left) and Betty Diamond received top honors from the American College of Rheumatology (ACR) and the Association of Rheumatology Professionals. (Photo: Business Wire)

MANHASSET, N.Y.--(BUSINESS WIRE)--In recognition of their ongoing research and leadership in rheumatology, The Feinstein Institutes for Medical Research’s Betty Diamond, MD, and Anne Davidson, MBBS, have been awarded top honors by the American College of Rheumatology (ACR) and the Association of Rheumatology Professionals. The pair was formally recognized during the ACR Convergence 2022 annual conference, November 10-14 in Philadelphia, Pennsylvania.

Dr. Diamond received the highest award that the ACR bestows, the Presidential Gold Medal. This award acknowledges the outstanding achievements in rheumatology over the span of a career for people who have made contributions to the field through clinical medicine, research, education or administration.

“To beat disease, you need to first understand what’s driving it at the molecular, most basic level. It has been my career’s mission to explore conditions like lupus to better diagnose and find treatments,” said Dr. Diamond, the Maureen and Ralph Nappi Professor of Autoimmune Diseases, and director of the PhD and MD/PhD programs of the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. “I am honored by these recognitions and hope to inspire future generations of scientists to continue this important work.”

Dr. Diamond is the director of the Institute of Molecular Medicine at the Feinstein Institutes and a pioneer in the basic science research of autoimmune diseases, particularly systemic lupus erythematosus. For more than four decades, Dr. Diamond has dedicated her career to the study of DNA-reactive B cells, autoantibodies and their origin and effect on the body. She has focused on the impact these antibodies have on the brain and how they may contribute to changes in cognition or behavior in patients with lupus. Dr. Diamond was elected to The National Academy of Sciences (NAS) in May 2022 for her research in molecular medicine.

Dr. Davidson is a professor in the Institute of Molecular Medicine at the Feinstein Institutes and also the program director of the Rheumatology fellowship at Northwell Health. She received one of the 2022 Master of the ACR Designation Recognition, which is one of the highest honors that the College bestows on its distinguished members. The designation of Master is conferred on ACR members who have made outstanding contributions to the field of rheumatology and devoted their long careers to furthering rheumatology research and improving clinical treatment standards.

“It is an honor to receive this award and be among so many colleagues and friends who have dedicated their lives to the field of rheumatology,” said Dr. Davidson, professor of Molecular Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. “I am eager to continue to advance this research that one day may help find effective treatments for lupus and other rheumatic diseases.”

Dr. Davidson and her lab’s research focus is to understand more about the regulation of autoantibody-producing B cells as well as other molecules related to organ inflammation. She is working on translational clinical trials to determine the efficacy and mechanism of action for new treatments.

“Drs. Diamond and Davidson are leaders in their fields of rheumatology and molecular medicine,” said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes and Karches Family Distinguished Chair in Medical Research. “This recognition by their peers is significant recognition for successes in advancing research and promoting collaboration.”

About the Feinstein Institutes

The Feinstein Institutes for Medical Research is the home of the research institutes of Northwell Health, the largest health care provider and private employer in New York State. Encompassing 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health system science, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we produce knowledge to cure disease, visit http://feinstein.northwell.edu and follow us on LinkedIn

Contacts

Matthew Libassi
631-793-5325
mlibassi@northwell.edu

Industry:

The Feinstein Institutes for Medical Research

Release Versions
English

Contacts

Matthew Libassi
631-793-5325
mlibassi@northwell.edu

More News From The Feinstein Institutes for Medical Research

Northwell to Launch Long Island’s First Pancreas Transplant Program

MANHASSET, N.Y.--(BUSINESS WIRE)--Northwell Health has received approval to launch Long Island’s first adult pancreas transplant program, according to a letter from the New York State Department of Health (DOH). The Northwell Transplant Institute at North Shore University Hospital (NSUH) recently hosted a site visit with DOH officials, the final hurdle before opening the program to new patients. Northwell’s pancreas program will open access to patients across the greater New York and southern C...

32BJ Health Fund and Northwell Direct Announce Largest Direct Healthcare Contract of its Kind in the Country, Delivering Major Savings and Expanding Access to Care

NEW YORK--(BUSINESS WIRE)--32BJ Health Fund, the union health fund representing 100,000 building service workers in the New York metro area, and Northwell Direct, a direct-to-employer health care network that partners directly with employers and labor unions to provide health benefits solutions to their employees, today announced a historic deal that will significantly expand access to high-quality care for 32BJ members and their families while delivering dramatic savings to patients, unions an...

Feinstein Institutes’ Researchers Develop Promising Therapeutic for Sepsis-Induced Acute Lung Injury

MANHASSET, N.Y.--(BUSINESS WIRE)--Scientists at Northwell Health’s Feinstein Institutes for Medical Research are making strides in controlling the severe inflammation that is the hallmark of sepsis. This severe condition occurs when the body’s immune system reaction to infection causes it to attack its own tissues and organs, often resulting in organ failure or death. Researchers have uncovered a critical mechanism driving acute lung injury (ALI) in sepsis, identifying a novel subset of neutrop...
Back to Newsroom